Bill Details

HRES.172 - 119th Congress

Track Raising awareness for the sarcoma cancer chordoma.? Stop tracking Raising awareness for the sarcoma cancer chordoma.?

When you track this bill you will receive emails when the bill has been updated.

You will no longer receive emails when this bill is updated.

Status
  1. Introduced
  2. Passed House
  3. Passed Senate
  4. To President
  5. Law
Latest action
2025-02-27 - Referred to the House Committee on Energy and Commerce.
Introduced Date
2025-02-27
Policy Area
Health
Committees
6
0

AI Summary This summary was generated by AI from the bill text. AI can get information wrong.

This resolution says the House of Representatives supports greater awareness and more help for people with chordoma, a rare but serious bone cancer that grows in the skull and spine. It explains that chordoma can affect people of any age, is hard to treat because it is often near the brain stem, spinal cord, nerves, and blood vessels, and can come back even after surgery or radiation. The resolution says there are still no drugs known to cure or reliably control the disease, so patients and families need more funding, better research, and faster progress toward new diagnoses and treatments.

  • Chordoma is described as a slow-growing but aggressive bone cancer that affects more than 25,000 people worldwide.
  • About 300 people in the United States are diagnosed with chordoma each year.
  • The resolution says better early diagnosis is needed, along with new treatments, tests, and cures.
  • It also calls for fewer barriers between research and real-world treatment, and for drug development that focuses more on patients’ needs.

Official Summaries

This resolution expresses the sense of the House of Representatives of the need for increased funding and support for diagnosis, treatments, and cures for chordoma (a bone cancer of the skull and spine).

Current Full Text

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 172 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
H. RES. 172

           Raising awareness for the sarcoma cancer chordoma.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 27, 2025

    Mr. Johnson of Georgia (for himself, Mrs. McBath, Ms. Wilson of 
    Florida, Ms. Velazquez, and Ms. Norton) submitted the following 
 resolution; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                               RESOLUTION


 
           Raising awareness for the sarcoma cancer chordoma.

Whereas chordoma is a slow growing, yet aggressive bone cancer of the skull and 
        spine;
Whereas it strikes people of all ages and affects more than 25,000 individuals 
        worldwide;
Whereas, each year, thousands of people are diagnosed with chordoma including 
        about 300 people annually in the United States;
Whereas chordomas are among the most complicated tumors to treat due to 
        involvement of critical structures such as the brain stem, spinal cord, 
        and important nerves and arteries;
Whereas surgery or radiation performed by a skilled treatment team can be 
        curative for some patients, but even with the best care possible, the 
        recurrence rate remains high; and
Whereas no drugs are known to cure or effectively control the disease, meaning 
        that patients whose disease progresses after exhausting surgical and 
        radiation options have little hope for a full recovery: Now, therefore, 
        be it
    Resolved, That it is the sense of the House of Representatives that 
chordoma patients and families need increased funding and support for--
            (1) accurate and early diagnosis;
            (2) the development of new treatments, diagnostics, and 
        cures;
            (3) fewer hurdles between research and new treatments; and
            (4) patient-centric approaches to drug discovery and 
        development.
                                 <all>